🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06714578
Starting soon Observational

Construction of a Risk Screening Tool for New Psychoactive Substance Misuse Among Adolescents and Young Adults

NCT06714578 · tracked via the Priya Life Science China tracker
Sponsor
Wei XIA, PhD
Phase
Observational
Started
2024-12-15
Last updated
2024-12-18

Condition(s) studied

Drug MisuseAddiction

Investigational drug(s) / intervention(s)

Questionnaire and Physical Exam

Questionnaire and Physical Exam: The investigators use questionnaire to assess biological factors (sleep quality, externalizing problem behavior, prosocial tendencies, sensation seeking, and hedonic hunger), psychological factors (risk awareness of drug misusing, indulgence of drug misusing, self-efficacy of drug misusing, and ACEs), and social factors (whether work in a special place, whether have drug-addicts around, cognition of traditional drug types, and cognition of NPS types) and demographic data

Study summary

The goal of this observational study is to construct a risk tool available for screening young adults and adolescents at high risk of drug misuse and provides a chance for early intervention to young adults and adolescents at high risk of drug misuse, which prevent the onset and development of drug addiction in the future.The main question it aims to answer is:

1. Explore the occurrence and influencing factors of new psychoactive substance misuse among young adults and adolescents;
2. Construct a risk prediction model for new psychoactive substance misuse among young adults and adolescents and conduct internal verification of the model;
3. Based on the results of the prediction model, select the optimal model to initially form a concise scale "Screening Tool for the Risk of New Psychoactive Substance Misuse among Young Adults and Adolescents";
4. Conduct external verification of the tool, and revise and improve the screening tool, form the final version of the screening tool, and verify the application performance of the screening tool.

Eligibility

Sex
ALL
Min age
14 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Adolescents and young adults who were aged 14-35 years; * Adolescents and young adults could read and communicate in Chinese were invited to participate in this study Exclusion Criteria: * Adolescents and young adults who were unable to complete the questionnaire due to physical or psychological reasons.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sun Yat-sen University Guangzhou Guangdong

More Wei XIA, PhD trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06714578 on ClinicalTrials.gov ↗ ← All trials in China